Status:
UNKNOWN
68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
PDAC
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Fibroblast activation protein (FAP) is overexpressed in cancer-associated fibroblasts (CAFs), which constitutes a major proportion of cells within the tumor microenvironment, especially in primary pan...
Detailed Description
With an incidence rate of 10 cases per 100,000 people per year, cancer of the pancreas is the third most common malignancy of the gastrointestinal tract. The overall survival for patients with pancrea...
Eligibility Criteria
Inclusion
- Patients with suspected pancreatic lesions
- Signed written consent.
Exclusion
- pregnancy;
- breastfeeding;
- any medical condition that in the opinion of the investigator may significantly interfere with study compliance
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05275985
Start Date
March 1 2022
End Date
June 1 2023
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospita
Beijing, Beijing Municipality, China, 100730